AI and ML in Pharma: Redefining the Forecasting Landscape

95% of pharma companies are investing in AI – but the real transformation is still to come. Artificial Intelligence (AI) isn’t just changing how drugs are discovered, it’s redefining how the entire pharma ecosystem thinks about the future. As the pace of innovation accelerates, forecasting teams will need to evolve faster than ever before. Our […]

Share:

Download today








95% of pharma companies are investing in AI – but the real transformation is still to come.

Artificial Intelligence (AI) isn’t just changing how drugs are discovered, it’s redefining how the entire pharma ecosystem thinks about the future. As the pace of innovation accelerates, forecasting teams will need to evolve faster than ever before.

Our new infographic explores how AI could reshape forecasting over the next decade, from dynamic, self-learning models to more precise, data-driven decision-making.

Discover where AI is poised to have the biggest impact, what challenges stand in the way, and how forward-thinking organizations are preparing for a more intelligent forecasting era.

Get the infographic today!

Upcoming Webinar

China Pipelines, Western Portfolios

Tuesday 14th July 3pm BST | 10am ET

Western pharma committed close to $2 billion in licensing deals and acquisitions for China-originated assets in Q1 2026 alone.

Related Content